Yes. Should 'fair value' (may not hit) at least RM1. 40 before 11/11. Let's looking forward

Anyway, market sentiment is now looking to furniture stocks led by Liihen. I guess it will report a very strong results after MCO period. Same apply to Poh Huat. So both LiiHen and Poh Huat should be strong buy now given the "shaking" economy and subsequently weakening of Ringgit. Export related stocks should benefit from it.

Luxchem reported a handsome profit with rolling 4Q PE of 24x while Techem also recovered from loss. All with same reason...increase in selling price and margin. So, Don't you don't believe Samchem will do the same ? and Samchem is trading at undemanding PE of 11x ?

U will miss RM1.10 soon.....buy before you feel sorry

@ibojio...Refer my comment dated 20/10...."Historically, Samchem will announce its 3Q results not later than 10th of Nov. So, please stay on till 10/11"

liihen fly down pohuat also fly down

However, longer term wise, the company should experience a recovery in its current thin margin position due to the surge in demand of products to the healthcare, household and personal care sectors. I think this company still provide a cheap entry for COVID related exposure. so, for a long term investor and lower risk exposure, Samchem should be part of your portfolio. I am not super investors as I also don't have much exposure in glove companies (other than hit n run). So, invest base on your own risk appetite.

Historically, Samchem will announce its 3Q results not later than 10th of Nov. So, please stay on till 10/11. Will expect to announce a record hitting net profit and expansion in margin. 2Q results have already showing the trend. Samchem is also distributing a chemical call TDI. This chemical is in high demand and short of supply. Prices had shot up too. I believe the company will definitely benefit from it.
Frankly, given its usual thin margin, I don't expect the share price to shoot up like those glove companies. Let's be practical, given its current 4Q rolling PE of 12.7x, should I put a fair PE of 15x, we will expect the target price to hit RM1.40 once it announces the 3Q results before 10 of Nov. It may not look attractive to short term investors

Will Matrix also involve in healthcare in a big way ? then it will limit up like Mah Sing.

Time to buy back..as weaker retailers will "cut loss" after getting their bonus share today

@ solarise80 "Sell, making big loss in Japan, USA and China typhoon and flood, making huge loss in next quester" ? where u get all these info ?

@jungleboy...yes...51k unit (34k * 1.5)

Close at RM0.95. Adjusted BI should be RM0.63 (or RM0.635)

Advised to take profit as it is merely syndicate push higher for BI ex next Monday

Mickey mouse naysayers 3 stooges. Please visit TDM specialist for your mental treatments..

For those who miss RM1 mark.....sorry

@ winwinaaa I admitted to make "mistake" and took profit earlier. After reading Affin report issued today as well as seasonally quarterly strong results at year-end, I have started to buy-back and wait for its final quarterly announcement to decide further move. Let's buy it and keep it under the pillow until Xmas. Normally, the company will announce its results before 25/12

Affin has upgrade its target price to RM1.96 from RM1.61 earlier. Management indicate the order book is for deliveries up to February 2021 and capacity to expand by 30%. So we can expect its sales and profit to increase by 30% next year. Targt price should improve by 30% too to RM2 mil level

Samchem is much co-related to glove counters. Most glove companies had indicated that the raw material has also increased by some 10-20% month-on-month in view of surge in demand. Samchem should benefit from it as it is supplying the chemical to glove companies. We should expect a surge in its profit margin from hereon, and expect to record a historical high in quarterly profit in coming quarters. I may not be able to suggest any TP at the moment, as I want to see "how much" its profit margin improvement. Overall, this counter is still trading a low valuation, of < PE of 10x

Now ? technical sell ?

@usj101, pls refer my comments on 14/8, 5.59pm

Should take profit now. Why ? Because the warrants will expire in 21/10 and this will enlarge the share capital and dilute the EPS. The latest circular show that there are still have 26.8 mil outstanding warrants (a check show the original warrants were 53 mil. So it is almost half of it been exercised. Based on latest 230 mil shares in its latest reports, the dilution impact would be about 13%. Therefore, we may expect a "drop" in EPs even they can generate a higher profit by end of the year. Prefer to take profit first.

Nothing to do with bonus issue. It is non-event. Most important, it is undervalued, and rebound from bottom to a new height.

Director is buying lah...keep push up

Was told by fund that the company is very bullish on their orders

Any plan to privatize MNRB ? Given its NTA of RM3.00 against market price of RM1.10 ? maybe...maybe not...?

My post still around. Only a bit disappointed on 3sen dividend, which suppose to be 8sen min...

Only 3sen? Not 50%payout as promised in ladt AGM? PLEASE LAH...

Cherry still here. You are not alone

Hi guys n gals. There are some some excitement news going to announce soon. 1 of them you guys probably know was the possible of dividend announcement (either by cash or share). The board has announced / disclosed (but may not committed) to distribute at least 50~75% profit as dividend. Given its latest EPS of 16sen, with 60% pay-out, 10sen dividend is already on the card before AGM ! With this, we expect the share price will continue to trend higher toward RM1.50 or 6.7% dividend yield. It is still reasonable given many other traditional blue chips had declare lower or even no dividend.
Secondly and most importantly, the recent surge in the price could due to a possible securing a new insurance business, tie up with a financial institution in Malaysia. This will enhance its future profitability and sustainability of the dividend payment to shareholders. Being the country's biggest re-insurance company in Malaysia, I believe the new and additional business tie-up will augur well its future profitability.
Thirdly, I believe the recent change in Board member will also bring in more insurance business.
Valuation wise, this counter is still very undervalue given its low PE of 5x, with high asset backing of RM3 per share, plus the recent 7~10% sustainable dividend yield. If you guys still looking for counters (other than glove / healthcare or IT which surged strongly recently), MNRB could give you a better investment choice for you to sleep well at night.

Haha...better SELL. Look for company still profitable (even at lower profit) who can ride through the MCO period

Hi OpensSysInsider, just be a bit low profile.....SC is watching tight....

If you believe in glove stock and yet "dare not" take direct position in glove counters due to their high valuation (you personal think), then SamChem offers a very good entry points and can sleep well (follow CoolEye teaching). Refer to my earlier comments after their results announcement

Haha... Joke lah.. Why so serious... I mean limit up next Monday

Any of you here attending its Zoom analyst briefing, to be conducted next Mon (17aug)?. Please share. Thanks

@sime, the company will pay at least 30sen dividend on 17Aug, in addition 1 sen dividend to be declared later

Let's look at valuation....Its 1H EPS already hit 4.81sen. So, full 2020 year will hit 10sen easily. Given current share price of 97sen (or RM1 lah), PE only 10x which is dam low. Minimally with PE of 15x (which is too low for "glove" / "covid" related counter), price can easily hit RM1.50. Long term PE should be 20-25x or target price of RM2.00 to RM2.50. Another plus point, assuming it is consistent in giving dividend of 4 sen (as per last year - given major downtrend in profit this year), we can expect a yield of 4% which is good enough.
I think this counter cannot be ignored if you want to have some exposure in covid (or glove) counter. Glove counter is definitely too high to chase. All the best !

If u look at q-q results, the improvement due mainly to the reversal of forex loss from the IDR. Let's look at 1H results cumulatively where it get hit by the MCO period compared to 1H of last year, we can clearly notice that it can produce a similar results, which means the company profit margin start improving together with factory efficiency. Despite revenue down by 8%, gross profit improved 11%, together with PBT improvement of 10%. Dividend declaration of 1 sen is also within expectation.
Overall, it is a very good set of result. given current low PE valuation, we can expect the share price to continue to perform. I do not want to indicate any target price here. We should continue to hold on due to its improving profit margin and factory efficiency.

Prospect looks promising given by the management comment on the recovery in affected sectors such as agriculture, construction related sectors, semiconductor,furniture and polyurethene foam products. The management also sees opportunities for business growth, building on the back of the newly developed agencies and expansion of product portfolio during the first half of the year.

Try not to hold the warrants, and clear as soon as you can before expiry in October

I think lumber price in US may not affect so much. But the weakening of USD against RM will definitely affect the profit. So, the MCO (or Covid) and the forex impact will not do well for export company like Poh Huat. Given its warrants to expire coming October, the year end EPS will be further diluted. Looks like the dividend is merely sweeter. Don't fall into "valuation trap"

QR ? no need to speculate. it is sure in red. only how "red" it is. If you think red is bad, then better close off position today

Ignoring thos x factors recently. If u study its fundamentals, they are generating good ROE, PBT margin ans most importantly, paying consistent dividend of closed to 7%. Another net cash company with no problem paying dividend. I expect its share price to hit RM2. 40 level before stablise.

Results are expected to release next week. Expect to boom up lah. Why ? because demand dam high, and start increase ASP, and improving margin. Expect a reversal of its forex loss. So, will limit up again due to very bright prospect.

YES....Very FAST....buy first before result announcement soon. The strengthening of RM will reverse the earlier forex loss...another x factor o look at

https://klse.i3investor.com/blogs/lionind/2020-08-06-story-h1511561570-Samchem_Beneficiary_of_Raw_Chemical_Material_supply_to_support_healthca.jsp

today will hit RM1.32

wait for result announcement...

Was told TA Research issued an updated report, upgrading target price to RM1.42. Anybody here can share the report ?

ASP will increase slowly...don't worry...it is a counter too cheap to ignore. PE at 10x++, ROE 10%++, dividend at 3%++

the only problem with this company is too low net margin. Can it be like glove company, to further increase unit price ?